3T Biosciences is an immunotherapy company. It develops therapies against cancer by combining experimental biology and artificial intelligence. The Company uses machine learning to predict what chemicals affect cancer cells and modifies T cells.
|HQ||South San Francisco, CA, US||Map|
|Employees (est.) (Sept 2021)||21|
3T Biosciences total Funding
3T Biosciences latest funding size
Time since last funding
|4 years ago|
3T Biosciences investors
|Menlo Ventures, CRV, Asset Management Ventures (AMV), Sean Parker, OS Fund, Thiel Capital, Starlight Ventures|
3T Biosciences has 210 Twitter Followers. The number of followers has increased 1.1% month over month and increased 6.1% quarter over quarter
When was 3T Biosciences founded?
3T Biosciences was founded in 2017.
Who are 3T Biosciences key executives?
3T Biosciences's key executives are Marvin Gee, John Connolly and Leah Sibener.
How many employees does 3T Biosciences have?
3T Biosciences has 21 employees.
Who are 3T Biosciences competitors?
Competitors of 3T Biosciences include Virogin Biotech, Silverback Therapeutics and Meabco.
Where is 3T Biosciences headquarters?
3T Biosciences headquarters is located at Building 84, 681 Gateway Blvd, South San Francisco.
Where are 3T Biosciences offices?
3T Biosciences has an office in South San Francisco.
How many offices does 3T Biosciences have?
3T Biosciences has 1 office.
Receive alerts for 300+ data fields across thousands of companies